Your browser doesn't support javascript.
loading
The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs.
Stabile, Roberto; Cabezas, Mario Román; Verhagen, Mathijs P; Tucci, Francesco A; van den Bosch, Thierry P P; De Herdt, Maria J; van der Steen, Berdine; Nigg, Alex L; Chen, Meng; Ivan, Cristina; Shimizu, Masayoshi; Koljenovic, Senada; Hardillo, Jose A; Verrijzer, C Peter; Baatenburg de Jong, Robert J; Calin, George A; Fodde, Riccardo.
Affiliation
  • Stabile R; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Cabezas MR; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Verhagen MP; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Tucci FA; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van den Bosch TPP; European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
  • De Herdt MJ; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van der Steen B; Department of Otorhinolaryngology and Head & Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Nigg AL; Department of Otorhinolaryngology and Head & Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Chen M; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ivan C; Department of Translational Molecular Pathology and Center of Department of Translational Molecular Pathology, and Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shimizu M; Department of Translational Molecular Pathology and Center of Department of Translational Molecular Pathology, and Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Koljenovic S; Caris Life Science, Irving, TX, USA.
  • Hardillo JA; Department of Translational Molecular Pathology and Center of Department of Translational Molecular Pathology, and Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Verrijzer CP; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Baatenburg de Jong RJ; Department of Pathology, Antwerp University Hospital, 2650, Edegem, Belgium.
  • Calin GA; Department of Otorhinolaryngology and Head & Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Fodde R; Department of Biochemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
Cell Death Dis ; 14(5): 337, 2023 05 22.
Article in En | MEDLINE | ID: mdl-37217493
ABSTRACT
Cyclin-dependent kinase 2-associated protein 1 (CDK2AP1; also known as deleted in oral cancer or DOC1) is a tumor suppressor gene known to play functional roles in both cell cycle regulation and in the epigenetic control of embryonic stem cell differentiation, the latter as a core subunit of the nucleosome remodeling and histone deacetylation (NuRD) complex. In the vast majority of oral squamous cell carcinomas (OSCC), expression of the CDK2AP1 protein is reduced or lost. Notwithstanding the latter (and the DOC1 acronym), mutations or deletions in its coding sequence are extremely rare. Accordingly, CDK2AP1 protein-deficient oral cancer cell lines express as much CDK2AP1 mRNA as proficient cell lines. Here, by combining in silico and in vitro approaches, and by taking advantage of patient-derived data and tumor material in the analysis of loss of CDK2AP1 expression, we identified a set of microRNAs, namely miR-21-5p, miR-23b-3p, miR-26b-5p, miR-93-5p, and miR-155-5p, which inhibit its translation in both cell lines and patient-derived OSCCs. Of note, no synergistic effects were observed of the different miRs on the CDK2AP1-3-UTR common target. We also developed a novel approach to the combined ISH/IF tissue microarray analysis to study the expression patterns of miRs and their target genes in the context of tumor architecture. Last, we show that CDK2AP1 loss, as the result of miRNA expression, correlates with overall survival, thus highlighting the clinical relevance of these processes for carcinomas of the oral cavity.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Mouth Neoplasms / Tumor Suppressor Proteins / MicroRNAs / Squamous Cell Carcinoma of Head and Neck Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Mouth Neoplasms / Tumor Suppressor Proteins / MicroRNAs / Squamous Cell Carcinoma of Head and Neck Limits: Humans Language: En Year: 2023 Type: Article